Canada Markets closed

Small Pharma Inc. (DMT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1200+0.0100 (+9.09%)
At close: 03:59PM EDT
Sign in to post a message.
  • C
    Chris
    it really doesn't help that Rand and his wife keep dumping shares.
  • J
    JUSTIN
    Anyone know why the 20% drop today? Some bad news that I can’t find?
  • j
    j
    Hey All. Any body still paying attention to this stock. Comments seam to have gone to sleep.
  • J
    JUSTIN
    Any reason in particular for the 30% fall today?
  • T
    Tyler
    There’s still mega potential here. Very early stages
  • V
    V
    DMT has been so inconsistent as of late. Starting to feel like a pendulum.
  • T
    Travis
    Peter Rands presenting for Small Pharma right now at the Microdose DMT Conference
  • C
    CaudHenry
    “ The clinical trials began in January and if successful, the firm hopes to be able to start offering it as a licensed treatment in connection with therapy within six years.”
  • M
    Mike
    anybody here? whats everyones average
  • V
    V
    DMT is a hidden gem waiting to be discovered. One of the better psychedelic companies out there.
  • V
    V
    Will this ever make it back to 70 cents?
  • M
    Mike
    Rands says that Small Pharma has an extensive patent portfolio, the bulk of which is in tryptamines and psychedelic tryptamines. 26 of their patent applications are related to psychedelic tryptamines. Many are focused on the DMT molecule without any functional changes to it.
    Rands adds that Small Pharma did develop a technology that uses deuterium to change the half-life of the drug and that two of their preclinical compounds are based on that technology platform.

    https://thedalesreport.com/psychedelics/small-pharma-was-established-to-make-medicine-peter-rands-director-and-ceo/
    We’re pleased to welcome to The Dales Report Peter Rands, the Director and CEO of Small Pharma to discuss his company and their focus on DMT.
    We’re pleased to welcome to The Dales Report Peter Rands, the Director and CEO of Small Pharma to discuss his company and their focus on DMT.
    thedalesreport.com
  • j
    j
    Is anybody finding any new information regarding this stock, or is there anybody else talking about this company?
  • C
    Charles
    No one paying any attention to this stock. Yet it is up about 30% ytd.
  • i
    i
    What's wrong with this stock?
  • V
    V
    25% drop - no news? Some one is really messing with this stock.
  • C
    Chris
    still has $50M+ in cash? Relatively clean cap table? 86M m. cap? I'll take that bet.
  • M
    Mike
    awesome week for small pharma inc :) i want to buy more shares but its hard to justify without any more information/news
  • N
    NuNrg
    Stonk
  • j
    j
    The first sign of green and I’m in for another 500.